These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 16076935

  • 1. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
    Escubedo E, Chipana C, Pérez-Sánchez M, Camarasa J, Pubill D.
    J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
    [Abstract] [Full Text] [Related]

  • 2. Free radical production induced by methamphetamine in rat striatal synaptosomes.
    Pubill D, Chipana C, Camins A, Pallàs M, Camarasa J, Escubedo E.
    Toxicol Appl Pharmacol; 2005 Apr 01; 204(1):57-68. PubMed ID: 15781294
    [Abstract] [Full Text] [Related]

  • 3. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
    Chipana C, Camarasa J, Pubill D, Escubedo E.
    Neuropharmacology; 2006 Sep 01; 51(4):885-95. PubMed ID: 16901518
    [Abstract] [Full Text] [Related]

  • 4. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
    Escubedo E, Camarasa J, Chipana C, García-Ratés S, Pubill D.
    Int Rev Neurobiol; 2009 Sep 01; 88():121-66. PubMed ID: 19897077
    [Abstract] [Full Text] [Related]

  • 5. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
    Mogg AJ, Whiteaker P, McIntosh JM, Marks M, Collins AC, Wonnacott S.
    J Pharmacol Exp Ther; 2002 Jul 01; 302(1):197-204. PubMed ID: 12065717
    [Abstract] [Full Text] [Related]

  • 6. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
    Chipana C, Torres I, Camarasa J, Pubill D, Escubedo E.
    Neuropharmacology; 2008 Jun 01; 54(8):1254-63. PubMed ID: 18455739
    [Abstract] [Full Text] [Related]

  • 7. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
    Chipana C, García-Ratés S, Camarasa J, Pubill D, Escubedo E.
    Neurochem Int; 2008 Feb 01; 52(3):401-10. PubMed ID: 17716785
    [Abstract] [Full Text] [Related]

  • 8. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
    Wu PH, Shen YC, Wang YH, Chi CW, Yen JC.
    Toxicology; 2006 Sep 21; 226(2-3):238-45. PubMed ID: 16887252
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.
    Neurobiol Dis; 2011 Jun 21; 42(3):391-403. PubMed ID: 21303698
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of both alpha7* and beta2* nicotinic acetylcholine receptors is necessary to prevent development of sensitization to cocaine-elicited increases in extracellular dopamine levels in the ventral striatum.
    Zanetti L, de Kerchove D'Exaerde A, Zanardi A, Changeux JP, Picciotto MR, Zoli M.
    Psychopharmacology (Berl); 2006 Aug 21; 187(2):181-8. PubMed ID: 16826402
    [Abstract] [Full Text] [Related]

  • 11. Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals.
    Northrop NA, Smith LP, Yamamoto BK, Eyerman DJ.
    J Pharmacol Exp Ther; 2011 Mar 21; 336(3):900-7. PubMed ID: 21159748
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice.
    Zanetti L, Picciotto MR, Zoli M.
    Psychopharmacology (Berl); 2007 Feb 21; 190(2):189-99. PubMed ID: 17061109
    [Abstract] [Full Text] [Related]

  • 13. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q, Xie X, Emadi S, Sierks MR, Wu J.
    Neuropharmacology; 2015 Oct 21; 97():457-63. PubMed ID: 25959067
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse.
    Fantegrossi WE, Ciullo JR, Wakabayashi KT, De La Garza R, Traynor JR, Woods JH.
    Neuroscience; 2008 Jan 24; 151(2):533-43. PubMed ID: 18082974
    [Abstract] [Full Text] [Related]

  • 15. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA, Moszczynska A.
    J Neurochem; 2016 Feb 24; 136(3):510-25. PubMed ID: 26465779
    [Abstract] [Full Text] [Related]

  • 16. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors.
    Tucci SA, Genn RF, File SE.
    Neuropharmacology; 2003 Mar 24; 44(3):367-73. PubMed ID: 12604094
    [Abstract] [Full Text] [Related]

  • 17. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y, Martin JL, Ali SF.
    Synapse; 1999 Dec 15; 34(4):305-12. PubMed ID: 10529724
    [Abstract] [Full Text] [Related]

  • 18. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE, O'Banion MK, Cory-Slechta DA, Olschowka JA, Opanashuk LA.
    Neurotoxicology; 2015 Sep 15; 50():131-41. PubMed ID: 26283213
    [Abstract] [Full Text] [Related]

  • 19. The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
    Kim MN, Jutkiewicz EM, Zhang M, Gnegy ME.
    Neuropharmacology; 2011 Jun 15; 60(7-8):1126-34. PubMed ID: 20971124
    [Abstract] [Full Text] [Related]

  • 20. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A, Wells PG.
    Free Radic Biol Med; 2015 Dec 15; 89():358-68. PubMed ID: 26427884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.